Michelle Tagliaferri, PA

Michelle Tagliaferri practices at Erie VA Medical Center in Erie, Pennsylvania, part of Veterans Health Administration.

Michelle Tagliaferri's NPI, 1801887690, was assigned on November 2, 2005. Michelle Tagliaferri holds New York license 008452.

Michelle Tagliaferri's primary practice is Erie VA Medical Center, at 135 East 38th Street, Erie, PA 16504 in Erie County. The practice phone is (814) 860-2576.

Michelle Tagliaferri's primary practice is Erie VA Medical Center in Erie, Pennsylvania, part of Veterans Health Administration. The medical group on file is Schweiger Dermatology Group. Dmand AI also links Michelle Tagliaferri to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Michelle Tagliaferri practices, 2 sites in all. Vendor and product names are available with a free account.

Physician assistant is Michelle Tagliaferri's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Michelle Tagliaferri is licensed in New York.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, corns and calluses, hives and itchy rashes among the conditions Michelle Tagliaferri treats.

CMS data shows 4,456 Medicare services from Michelle Tagliaferri across 16 procedure codes in 2024, for 1,240 Medicare patients. Medicare paid $146,210 for them. Every service was in an office.

CMS counts 1,240 Medicare patients who saw Michelle Tagliaferri in 2024. The largest group is 65 to 74, with 598 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 4% are also on Medicaid. Their average risk score is 0.80, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Michelle Tagliaferri's median patient age at 61, with 70% women.

In 2024, Michelle Tagliaferri wrote 1,631 Medicare Part D claims for 526 patients. 81% of them were for generic drugs. CMS names the drug for 1,439 of them, across 29 drugs with 11 or more claims each, at $1,229,967 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Michelle Tagliaferri for performance year 2024, reported as part of a group. Michelle Tagliaferri accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 178 general payments to Michelle Tagliaferri from 18 drug and device companies in 2025. Food and beverage make up the largest share, 98% of the total. Abbvie Inc. paid the most, $629.